Asthma and lower airway diseaseD prostanoid receptor 2 (chemoattractant receptor–homologous molecule expressed on TH2 cells) protein expression in asthmatic patients and its effects on bronchial epithelial cells
Key words
Abbreviations used
Cited by (0)
Supported by AstraZeneca. C.E.B. is a Wellcome Trust Senior Clinical Fellow. The research was performed in laboratories funded in part by the European Regional Development Fund (ERDF 05567). This study was also supported in part by the National Institute for Health Research Leicester Respiratory Biomedical Research Unit and AirPROM (FP7-270194). The views expressed are those of the author(s) and not necessarily those of the National Health Service, the National Institute for Health Research or the Department of Health. The European Regional Development Fund had no involvement in the design of the study, data collection, analysis and interpretation of the data, in the writing of the manuscript, or in the decision to submit the manuscript.
Disclosure of potential conflict of interest: S. E. Stinson has received research support from and owns shares of AstraZeneca. C. E. Brightling has received research support from GlaxoSmithKline, MedImmune, Novartis, Roche, and Chiesi; has consultant arrangements with GlaxoSmithKline, MedImmune, Boehringer Ingelheim, Novartis, Roche, and Chiesi; and has received travel support from Boehringer Ingelheim. Y. Amrani declares no relevant conflicts of interest.
- ∗
These authors contributed equally to this work as co-senior authors.